Patents by Inventor Philippe Reulet

Philippe Reulet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100323390
    Abstract: The invention relates to the direct selection of metabolic pathways having a determined function in the transformation of a substrate {Ai} into a target product {B}, which is of interest in the industrial, pharmaceutical or agri-food sectors. More specifically, the invention relates to the detection, within metagenomic libraries, of novel biosynthesis pathways involved in a biochemical reaction having a known product {B}. The selection and characterisation of said novel metabolic pathways enables {B} to be produced enzymatically. The invention provides an alternative to the chemical synthesis of the molecule in question {B}. Moreover, and above all, the invention can be used specifically to target and exploit the only metabolic pathways enabling the transformation of {Ai} into {B}, while eliminating the associated metabolic pathways that can catabolise the target product {B}.
    Type: Application
    Filed: August 31, 2010
    Publication date: December 23, 2010
    Applicant: LIBRAGEN
    Inventors: Pierre Monsan, Claude Bensoussan, Philippe Reulet, Renaud Nalin, Patrick Robe, Karine Tuphile, Benjamin Gillet, Pierre Pujic
  • Patent number: 7846874
    Abstract: The invention relates to the direct selection of metabolic pathways having a determined function in the transformation of a substrate {Ai} into a target product {B}, which is of interest in the industrial, pharmaceutical or agri-food sectors. More specifically, the invention relates to the detection, within metagenomic libraries, of novel biosynthesis pathways involved in a biochemical reaction having a known product {B}. The selection and characterization of said novel metabolic pathways enables {B} to be produced enzymatically. The invention provides an alternative to the chemical synthesis of the molecule in question {B}. Moreover, and above all, the invention can be used specifically to target and exploit the only metabolic pathways enabling the transformation of {Ai} into {B}, while eliminating the associated metabolic pathways that can catabolise the target product {B}.
    Type: Grant
    Filed: March 22, 2005
    Date of Patent: December 7, 2010
    Assignee: Libragen
    Inventors: Pierre Monsan, Claude Bensoussan, Philippe Reulet, Renaud Nalin, Patrick Robe, Karine Tuphile, Benjamin Gillet, Pierre Pujic
  • Publication number: 20070184449
    Abstract: The invention relates to the direct selection of metabolic pathways having a determined function in the transformation of a substrate {Ai} into a target product {B}, which is of interest in the industrial, pharmaceutical or agri-food sectors. More specifically, the invention relates to the detection, within metagenomic libraries, of novel biosynthesis pathways involved in a biochemical reaction having a known product {B}. The selection and characterisation of said novel metabolic pathways enables {B} to be produced enzymatically. The invention provides an alternative to the chemical synthesis of the molecule in question {B}. Moreover, and above all, the invention can be used specifically to target and exploit the only metabolic pathways enabling the transformation of {Ai} into {B}, while eliminating the associated metabolic pathways that can catabolise the target product {B}.
    Type: Application
    Filed: March 22, 2005
    Publication date: August 9, 2007
    Inventors: Pierre Monsan, Claude Bensoussan, Philippe Reulet, Renaud Nalin, Patrick Robe, Karine Tuphile, Benjamin Gillet, Pierre Pujic